The agreement provides WeightJust with the exclusive rights to sell in the UK and the Republic of Ireland and includes minimum purchase requirements.
According to Misonix, the SonaStar is used by neuro and general surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. In addition, OsteoSculpt bone shaving technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.
Michael McManus Jr, president and CEO of Misonix, said: "Misonix is pleased to add WeightJust to our growing sales organization. WeightJust's established position in the neurosurgery and general surgery distribution channels should prove beneficial for both companies as we expand our presence in the UK and the Republic of Ireland."
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index